
Explore complete financial details, shareholding patterns, and trade unlisted shares securely.
Current Offer Price
Veeda Clinical Research Limited, established in 2004, is one of India’s leading independent clinical research organizations providing end-to-end services to global pharmaceutical companies, covering everything from pre-clinical research to early and late-phase clinical trials. The company offers a wide range of services including bioavailability and bioequivalence studies, bioanalytical testing, pharmacovigilance, and medical writing, helping clients develop and launch new drugs efficiently and cost-effectively. With multiple advanced research facilities in Ahmedabad, Mehsana, and Bangalore, and a presence across 27 countries, Veeda has built a strong global client base including well-known pharma companies. The company has also strengthened its capabilities through strategic acquisitions like Heads and Bioneeds, along with a joint venture in biosimilars, while maintaining strong regulatory compliance with successful inspections from global authorities. Supported by the growing demand ...
| Veeda Clinical Research Limited Price | ₹428.00 Per Equity Share |
| Lot Size | 100 Shares |
| 52 Week High | 475 Shares |
| 52 Week Low | 428 Shares |
| Depository | NSDL & CDSL |
| PAN Number | AACCC3633Q |
| ISIN Number | INE01HQ01026 |
| CIN | U73100GJ2004PLC044023 |
| RTA | Link Intime India Pvt Ltd. |
| Market Cap (in Cr.) | 2815.00 |
| P/E Ratio | 0.00 |
| P/B Ratio | 3.26 |
| D/E Ratio | 0.47 |
| ROE | -7.77 |
| Book Value | 131.38 |
| Face Value | 2.00 |
| Total Shares | 65777495 |
| Field | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| da | 25 | 38 | 53 | 148 |
| eps | 9.46 | 8 | -0.04 | -10.19 |
| npm | 17.36 | 10.27 | -0.08 | -10.98 |
| opm | 21.53 | 25.18 | 13.66 | 20.49 |
| pat | 50 | 42 | -0.3 | -67 |
| pbt | 65 | 59 | 3.3 | -66 |
| tax | 15 | 17 | 3.6 | 1 |
| ebit | 37 | 65 | 0 | -23 |
| ebitda | 62 | 103 | 53 | 125 |
| revenue | 288 | 409 | 388 | 610 |
| pbt margins | 22.57 | 14.43 | 0.85 | -10.82 |
| ebit margins | 12.85 | 15.89 | 0 | -3.77 |
| finance cost | 10 | 14 | 14 | 54 |
| other income | 39 | 8 | 19 | 11 |
| gross margins | 90.28 | 91.93 | 90.21 | 93.28 |
| other expenses | 111 | 164 | 171 | 223 |
| change in inventory | 0 | 0 | 0 | 0 |
| cost of material consumed | 28 | 33 | 38 | 41 |
| employee benefit expenses | 87 | 109 | 126 | 221 |